Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-098418
Filing Date
2025-10-14
Accepted
2025-10-14 09:03:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 27234
2 JOINT FILING AGREEMENT ea026106301ex99-a_invivyd.htm EX-99.A 18458
  Complete submission text file 0001213900-25-098418.txt   47457
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Subject) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92804 | Film No.: 251389988
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund III, L.P. (Filed by) CIK: 0001955982 (see all company filings)

EIN.: 880637097 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G